Next Gen Immuno-Oncology Congress

June 21-22, 2018 | Philadelphia - USA
CONFERENCE SPEAKERS
Advisors
Stefan Glueck
Stefan Glueck
Senior Vice President, Global Medical Affairs,
Celgene



Roy Baynes
Roy Baynes
Senior Vice President,
Merck



John Delaney
John Delaney
Executive Director, Research,
Amgen



Speakers
Eytan Barnea
Eytan Barnea
Founder and Chief Scientist,
BioIncept LLC



Ellen Pure
Ellen Pure
Professor and Chair, Department of Biomedical Sciences,
University of Pennsylvania



Terry Fisher
Terry Fisher
Director, Translational Science and Bioanalytical,
Vaccinex



Judi Wardwell-Swanson
Judi Wardwell-Swanson
Senior Application Scientist,
Insphero



Pirouz Daftarian
Pirouz Daftarian
Application Manager, IO/Vaccines,
MBL International /JSR Micro, Life Sciences Inc.



Raj Chavali
Raj Chavali
Senior Director,
Caris Lifesciences



Joost Oppenheim
Joost Oppenheim
Head, Cellular Immunology,
NIH



Christophe Queva
Christophe Queva
Chief Scientific Officer,
Oncorus



Ashok Shrivastava
Ashok Shrivastava
CEO,
Cure Pharmaceuticals



Mark Gardner
Mark Gardner
CEO,
OmniSeq



Patrick Hanley
Patrick Hanley
Director, GMP for Immunotherapy, Assistant Professor,
Children’s National Medical Centre



Frank Walsh
Frank Walsh
CEO,
Ossianix Inc.



Mithun Khattar
Mithun Khattar
Immuno-Oncology Lead,
Takeda Oncology



Lata Jayaraman
Lata Jayaraman
Head, Tumor Immunotherapy,
Seres Therapeutics



Gregory Alberts
Gregory Alberts
Global Subject Matter Expert,
Lonza Pharma Bioscience Solutions



Mark Paris
Mark Paris
Associate Director, Translational Applications,
Mitra Biotech



Holly Koblish
Holly Koblish
Director, Pharmacology,
ncyte



Papia Chakraborty
Papia Chakraborty
Senior Scientist, Head, Immuno-Oncology,
Medgenome



Pramod Srivastava
Pramod Srivastava
Director of the Carole and Ray Neag Comprehensive Cancer Cente,
University of Connecticut



Roy Baynes
Roy Baynes
Senior Vice President,
Merck



John Delaney
John Delaney
Executive Director, Research,
Amgen



Ildiko Csiki
Ildiko Csiki
Vice President, Clinical Development Immuno- Oncology,
Inovio



Ezio Bonvini
Ezio Bonvini
Senior Vice President, CSO,
MacroGenics



Stephen Schoenberger
Stephen Schoenberger
Professor of Immunology,
La Jolla Institute for Allergy and Immunology



Andrew Allen
Andrew Allen
CEO,
Gritstone Oncology



Wei Zhou
Wei Zhou
Senior Research Scientist,
The Jackson Laboratory



Rakesh Dixit
Rakesh Dixit
CEO,
Bionavigen



Stefan Glueck
Stefan Glueck
Senior Vice President, Global Medical Affairs,
Celgene



Daniel Powell
Daniel Powell
Associate Professor of Pathology and Laboratory Medicine,
University of Pennsylvania



Daniel Levey
Daniel Levey
Senior Director Vaccine Research,
Agenus



Wendy Clemens
Wendy Clemens
Vice President, Clinical Development,
Nektar Therapeutics



Natalie Russi
Natalie Russi
Scientific Project Manager,
Nebion



Lisa McNeil
Lisa McNeil
Director, Translational Medicine,
Genocea



Wayne Godfrey
Wayne Godfrey
Senior Director, Clinical Development,
Kite Pharma



Liang Deng
Liang Deng
Associate Member, Attending Physician,
Memorial Sloan Kettering Cancer Centre



Christopher Bunker
Christopher Bunker
Vice President, Business Development,
ACD-Bio-Biotechne